tirzepatide february 2025 FDA ban on compounded tirzepatide: Switch to name brand medications What Is Tirzepatide Used for?

Switching patterns following formulary change Switching from AOM tirzepatide remained rare prior to May 2025, averaging 0.6% of patients who switched to a different GLP-1 in the following month

Under-eating protein: Tirzepatide can cause up to 40% of weight loss to come from lean muscle rather than fat if protein intake is too low

Here is where each stands and how their approaches differ

Check your eligibility a few minutes of medical intake

Following FDA label recommendations, patients should consider smaller, lower-fat meals, especially during dose escalation or when experiencing gastrointestinal symptoms

Why it happens: Similar to nausea, vomiting can occur because the stomach is not emptying as quickly as usual